Detalles de la búsqueda
1.
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget's disease of bone.
Ann Rheum Dis
; 83(4): 529-536, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123339
2.
Genetic Screening of ZNF687 and PFN1 in a Paget's Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687.
Calcif Tissue Int
; 113(5): 552-557, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728743
3.
A Panel-Based Sequencing Analysis of Patients with Paget's Disease of Bone Suggests Enrichment of Rare Genetic Variation in regulators of NF-κB Signaling and Supports the Importance of the 7q33 Locus.
Calcif Tissue Int
; 109(6): 656-665, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34173013
4.
Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Calcif Tissue Int
; 106(5): 494-508, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025752
5.
Genetic Variation in RIN3 in the Belgian Population Supports Its Involvement in the Pathogenesis of Paget's Disease of Bone and Modifies the Age of Onset.
Calcif Tissue Int
; 104(6): 613-621, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726512
6.
Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Calcif Tissue Int
; 98(1): 1-17, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26445771
7.
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Aging Clin Exp Res
; 28(1): 1-16, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26746234
8.
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.
Lancet
; 382(9902): 1424-32, 2013 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927913
9.
Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
Calcif Tissue Int
; 94(3): 311-8, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24271562
10.
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Rheumatology (Oxford)
; 52(6): 1058-69, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23365149
11.
Health technology assessment in osteoporosis.
Calcif Tissue Int
; 93(1): 1-14, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23515633
12.
Postnatal growth defect in mice upon persistent Hoxa2 expression in the chondrogenic cell lineage.
Differentiation
; 83(3): 158-67, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22093256
13.
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms.
Mol Genet Metab
; 103(3): 287-92, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21501964
14.
Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse.
Front Genet
; 12: 705505, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34447412
15.
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
Hum Genet
; 128(6): 615-26, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20839008
16.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
; 373(9671): 1253-63, 2009 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19362675
17.
Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.
Curr Osteoporos Rep
; 8(3): 154-61, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20563900
18.
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort.
J Bone Miner Res
; 35(7): 1246-1252, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32176830
19.
Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Bone
; 124: 137-147, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31051315
20.
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.
BMJ Open
; 9(9): e030689, 2019 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488492